Difficulty: Medium
Average Score: 74%
Testbank
The nurse is discussing the new medication that a client will be taking for treatment of rheumatoid arthritis. Which disease-modifying antirheumatic drug (DMARD) will the nurse educate the client about?
Correct answer
A
Rationale
Methotrexate is the disease-modifying antirheumatic drug (DMARD) that the nurse will educate the client about for the treatment of rheumatoid arthritis. Methotrexate is commonly used as a first-line DMARD due to its ability to reduce inflammation and slow disease progression in rheumatoid arthritis, making it a key medication for managing this chronic condition.
B: Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that primarily provides pain relief and reduces inflammation but does not modify the disease course in rheumatoid arthritis.
C: Methylprednisolone is a corticosteroid used for its anti-inflammatory effects but does not have the disease-modifying properties characteristic of DMARDs like methotrexate.
D: Mercaptopurine azathioprine is an immunosuppressive medication that is used for certain conditions, but it is not a first-line DMARD for rheumatoid arthritis treatment.
B: Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that primarily provides pain relief and reduces inflammation but does not modify the disease course in rheumatoid arthritis.
C: Methylprednisolone is a corticosteroid used for its anti-inflammatory effects but does not have the disease-modifying properties characteristic of DMARDs like methotrexate.
D: Mercaptopurine azathioprine is an immunosuppressive medication that is used for certain conditions, but it is not a first-line DMARD for rheumatoid arthritis treatment.